Clinical Guidelines for APL Treatment
NCT02020161
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
200
Enrollment
OTHER
Sponsor class
Conditions
APL
Interventions
DRUG:
Atra
DRUG:
Idarubicin
DRUG:
methotrexate
Sponsor
PETHEMA Foundation